CN100581600C - Extracorporeal blood dialysis filtering method and apparatus for treating cerebral apoplexy - Google Patents
Extracorporeal blood dialysis filtering method and apparatus for treating cerebral apoplexy Download PDFInfo
- Publication number
- CN100581600C CN100581600C CN200310108368A CN200310108368A CN100581600C CN 100581600 C CN100581600 C CN 100581600C CN 200310108368 A CN200310108368 A CN 200310108368A CN 200310108368 A CN200310108368 A CN 200310108368A CN 100581600 C CN100581600 C CN 100581600C
- Authority
- CN
- China
- Prior art keywords
- lower cover
- plasma
- loam cake
- dialysis
- blood plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000006011 Stroke Diseases 0.000 title claims abstract description 23
- 238000000502 dialysis Methods 0.000 title claims abstract description 22
- 206010008190 Cerebrovascular accident Diseases 0.000 title claims abstract description 21
- 238000001914 filtration Methods 0.000 title claims abstract description 11
- 210000004369 blood Anatomy 0.000 title abstract description 13
- 239000008280 blood Substances 0.000 title abstract description 13
- 230000002490 cerebral effect Effects 0.000 title abstract description 7
- 238000000034 method Methods 0.000 title description 14
- 210000002381 plasma Anatomy 0.000 claims abstract description 47
- 239000012528 membrane Substances 0.000 claims abstract description 22
- 239000002502 liposome Substances 0.000 claims abstract description 13
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 claims description 5
- 238000001179 sorption measurement Methods 0.000 claims description 4
- 239000003292 glue Substances 0.000 claims description 2
- 101150071172 PCS2 gene Proteins 0.000 abstract description 3
- 239000002245 particle Substances 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 239000004531 microgranule Substances 0.000 description 7
- 239000003146 anticoagulant agent Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 229940127219 anticoagulant drug Drugs 0.000 description 4
- 206010008118 cerebral infarction Diseases 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005374 membrane filtration Methods 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 206010048962 Brain oedema Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- -1 Kynoar Polymers 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Images
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200310108368A CN100581600C (en) | 2003-10-31 | 2003-10-31 | Extracorporeal blood dialysis filtering method and apparatus for treating cerebral apoplexy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200310108368A CN100581600C (en) | 2003-10-31 | 2003-10-31 | Extracorporeal blood dialysis filtering method and apparatus for treating cerebral apoplexy |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1611273A CN1611273A (en) | 2005-05-04 |
CN100581600C true CN100581600C (en) | 2010-01-20 |
Family
ID=34758575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200310108368A Expired - Lifetime CN100581600C (en) | 2003-10-31 | 2003-10-31 | Extracorporeal blood dialysis filtering method and apparatus for treating cerebral apoplexy |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100581600C (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102015015597A1 (en) * | 2015-12-04 | 2017-06-08 | Fresenius Medical Care Deutschland Gmbh | Treatment of stroke by hemofiltration |
CN114225142A (en) * | 2021-10-29 | 2022-03-25 | 南京国青血液净化科技有限公司 | Blood purification device |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102240417B (en) * | 2011-07-11 | 2013-12-18 | 薛磊 | Blood filtration and transfusion bag with double layers of filter membranes |
CN106563183A (en) * | 2015-10-12 | 2017-04-19 | 江苏博发生物科技有限公司 | Blood purification filter for removing bilirubin |
WO2018139145A1 (en) * | 2017-01-30 | 2018-08-02 | 東レ株式会社 | Purification column |
CN109045379A (en) * | 2018-07-12 | 2018-12-21 | 安陆恩彼饲料有限公司 | A kind of plasma purification method |
-
2003
- 2003-10-31 CN CN200310108368A patent/CN100581600C/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102015015597A1 (en) * | 2015-12-04 | 2017-06-08 | Fresenius Medical Care Deutschland Gmbh | Treatment of stroke by hemofiltration |
CN114225142A (en) * | 2021-10-29 | 2022-03-25 | 南京国青血液净化科技有限公司 | Blood purification device |
Also Published As
Publication number | Publication date |
---|---|
CN1611273A (en) | 2005-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5679264A (en) | Gas plasma treated porous medium and method of separation using same | |
EP1993631B1 (en) | Regeneratable filter for extracorporal treatment of liquids containing particles and use thereof | |
AU631923B2 (en) | Filter for purification of platelets | |
EP0166325B1 (en) | Process and device for the selective separation of pathological and/or toxic species from blood or plasma with the use of filter candles | |
CN1073614A (en) | Method and apparatus from the biological fluid separated plasma | |
JPWO2006126497A1 (en) | Body fluid treatment filter device | |
JP2004130085A (en) | Selective deleukocytation unit for platelet product | |
US4663058A (en) | Process for continuous separation of leukocyte/platelet-enriched fraction from whole blood | |
CN100581600C (en) | Extracorporeal blood dialysis filtering method and apparatus for treating cerebral apoplexy | |
CN208943042U (en) | For treating the plasma filtering device of hyperlipidemia | |
US4765899A (en) | Apparatus for continuous separation of leukocyte/platelet-enriched fraction from whole blood | |
JPH04240456A (en) | Filter apparatus for removing leukocyte and method for using it | |
TW201936202A (en) | Toxin separator | |
JPS6036061A (en) | Blood purifying apparatus | |
JP2001061955A (en) | Autotransfusion device and method | |
CN2751810Y (en) | External blood plasma dialysis filtering box for treating cerebral apoplexy | |
WO2006012885A1 (en) | Filter system for treating liquids containing particles using membrane isolation and adsorption | |
EP0604590A4 (en) | Gas plasma treated porous medium and method of separation using same. | |
CN111035826A (en) | Blood purification device with membrane separation and perfusion coupling | |
CN114129802A (en) | Plasma lipid filter | |
JPH0614968B2 (en) | Leukocyte capture and separation device | |
CN216022409U (en) | Neuroimmune disease treatment system | |
CN217187206U (en) | Plasma lipid filter | |
CN205885876U (en) | Hyperlipidemia treatment filter | |
CN2643904Y (en) | Myocarditic virus filtration and removal device through extracorporeal circulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20060414 Address after: Block A, building 10, No. 1399 West Beijing Road, Shanghai Applicant after: Shanghai Jiangxia Blood Technology Co.,Ltd. Address before: No. 1733 Lianhua Road, Shanghai Applicant before: Shanghai Jianfu Biotech Co.,Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CI01 | Publication of corrected invention patent application |
Correction item: Inventor Correct: Huang Heping|Dong Qiang|Zhou Qingwen|Xue Jun|Han Xiang False: Huang Heping|Dong Qiang|Zhou Wenqing|Xue Jun|Han Xiang Number: 03 Volume: 26 |
|
CI03 | Correction of invention patent |
Correction item: Inventor Correct: Huang Heping|Dong Qiang|Zhou Qingwen|Xue Jun|Han Xiang False: Huang Heping|Dong Qiang|Zhou Wenqing|Xue Jun|Han Xiang Number: 03 Page: The title page Volume: 26 |
|
ERR | Gazette correction |
Free format text: CORRECT: INVENTOR; FROM: HUANG HEPING; DONG QIANG, ZHOU WENQING, XUE JUN, HAN XIANG TO: HUANG HEPING; DONG QIANG, ZHOU QINGWEN, XUE JUN, HAN XIANG |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20100120 |